Literature DB >> 5429105

Method for measuring cerebral dysfunction in patients with liver disease.

R Zeegen, J E Drinkwater, A M Dawson.   

Abstract

Objective tests of cerebral function were undertaken in 64 outpatients after portal decompression for intrahepatic portal hypertension. These involved scoring the errors in constructing a five-pointed star, and a simple modification of the Reitan trail making test. The first test was found to be less discriminating than the second. There was some correlation between the results and the presence or absence of overt encephalopathy, which-though generally mild-was present in 30 (47%) of the 64 patients.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5429105      PMCID: PMC1700753          DOI: 10.1136/bmj.2.5710.633

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Experiences with portacaval anastomosis. Analysis of 104 elective end-to-side shunts for the prevention of recurrent hemorrhage from esophagogastric varices (1952 through 1961).

Authors:  L M ROUSSELOT; W F PANKE; R F BONO; A H MORENO
Journal:  Am J Med       Date:  1963-03       Impact factor: 4.965

2.  Congenital hepatic fibrosis.

Authors:  D N KERR; C V HARRISON; S SHERLOCK; R M WALKER
Journal:  Q J Med       Date:  1961-01

3.  Psychiatric aspects of liver disease.

Authors:  E A DAVIDSON; W H SUMMERSKILL
Journal:  Postgrad Med J       Date:  1956-10       Impact factor: 2.401

4.  The neurological disorder associated with liver disease.

Authors:  R D ADAMS; J M FOLEY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

5.  A controlled study of the prophylactic portacaval shunt. A final report.

Authors:  R H Resnick; T C Chalmers; A M Ishihara; A J Garceau; A D Callow; E M Schimmel; E T O'Hara
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

6.  A sixteen-year experience with end-to-side portacaval shunt for varical hemorrhage: analysis of data and comparison with other types of portasystemic anastomoses.

Authors:  W F Panke; L M Rousselot; A R Burcheli
Journal:  Ann Surg       Date:  1968-12       Impact factor: 12.969

7.  Postshunt encephalopathy.

Authors:  W V McDermott; B A Barnes; G L Nardi; F W Ackroyd
Journal:  Surg Gynecol Obstet       Date:  1968-03

Review 8.  The present status of shunts for portal hypertension in cirrhosis.

Authors:  N D Grace; H Muench; T C Chalmers
Journal:  Gastroenterology       Date:  1966-05       Impact factor: 22.682

9.  Spleno-renal anastomosis: results in 47 cases.

Authors:  S B Renwick; J Loewenthal; F H Mills
Journal:  Med J Aust       Date:  1969-04-12       Impact factor: 7.738

  9 in total
  30 in total

Review 1.  Psychiatric aspects of portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; K Weissenborn; J Kornhuber; E Rüther
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Minimal hepatic encephalopathy impairs quality of life.

Authors:  Swastik Agrawal; Sridharan Umapathy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-04

4.  Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability.

Authors:  A Watanabe; T Tuchida; Y Yata; Y Kuwabara
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

5.  Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

Authors:  H O Conn
Journal:  Am J Dig Dis       Date:  1977-06

6.  Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.

Authors:  M L Zeneroli; G Pinelli; G Gollini; A Penne; E Messori; G Zani; E Ventura
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

7.  Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

Authors:  H Schomerus; W Hamster; H Blunck; U Reinhard; K Mayer; W Dölle
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

8.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

9.  Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.

Authors:  P L Lanthier; M Y Morgan
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

10.  Visual attention orienting in liver cirrhosis without overt hepatic encephalopathy.

Authors:  P Amodio; P Marchetti; F Del Piccolo; G Sartori; M Prior; C Merkel; A Gatta
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.